COVID-19 vaccines

27 Jul: Statement by President von der Leyen on a new milestone in the EU Vaccines Strategy

( Source: European Commission)

The EU has kept its word and delivered.

Our target was to protect 70% of adults in the European Union with at least one vaccination in July. 

Today we have achieved this target. And 57% of adults already have the full protection of double vaccination.

These figures put Europe among the world leaders.

The catch-up process has been very successful – but we need to keep up the effort.

The delta variant is very dangerous. I therefore call on everyone – who has the opportunity – to be vaccinated. For their own health and to protect others.

The EU will …

29 Jun: COVID-19: EU helps deliver vaccines to Kosovo

(Source: European Commission)

The European Union is helping Norway to deliver over 180,000 doses of COVID-19 vaccine to Kosovo, following Kosovo’s request for assistance via the EU Civil Protection Mechanism. The Commission coordinates and finances up to 75% of the costs for transporting the assistance.

Commissioner for Crisis Management, Janez Lenarčič, said: “The COVID-19 pandemic has affected all of us. The EU is committed to help share the vaccines globally – we can beat the pandemic only if we act together. I thank Norway for its generous offer to Kosovo. Our Emergency Response Coordination Centre is ready to help facilitate further …

20 May: Getting a patent waiver is not enough, says WTO chief to Trade Committee

(Source: European Parliament)

Parliament’s Committee on Trade debated on Thursday how to increase vaccine production effectively with WTO Director-General Dr Ngozi Okonjo-Iweala.

In reply to trade committee MEPs’ questions over what measures are needed to accelerate equitable access to vaccines, Dr Okonjo-Iweala argued in favour of expanding vaccine production and ending export restrictions.

She said: “Getting the Intellectual Property rights waiver for vaccines will not be enough”. She listed three other routes: reducing export restrictions and reinforcing supply chains for vaccines, working with manufacturers to expand production, including in emerging countries with idle capacity such as Indonesia, South Africa, Thailand …

19 May: MEPs split over waiver for COVID-19 vaccine patents

(Source: European Parliament)

At Wednesday’s debate on ensuring global access to shots, there was a lack of consensus among MEPs on a temporary waiver of patent rights for COVID-19 vaccines.

A number of speakers called on the Commission to support a waiver of the intellectual property rights (IPR) for COVID-19 vaccines as an essential element in accelerating the rollout of shots to low and middle income countries.

In turn, many MEPs argued a patent waiver is a “false good idea” that would not speed up the provision of vaccines and would harm innovation. Instead, they argued the Commission should push …